Treatment of hypotension caused by acute myocardial infarction, cardiopulmonary bypass, or pheochromocytoma resection; adjunctive therapy for shock or hypotension due to hypovolemia to temporarily maintain cerebral and coronary perfusion until adequate volume replacement takes effect; management of hypotension during spinal or epidural anesthesia; maintenance of blood pressure after resuscitation from cardiac arrest; first-line vasopressor in septic shock to improve tissue oxygenation; correction of non-shock-related intraoperative or postoperative hypotension with minimal risk of tachyarrhythmias due to its predominant α-adrenergic and weak β1-adrenergic activity.